Joinn Laboratories(China)Co.,Ltd. (603127.SS)
CNY 17.42
(0.87%)
CNY 17.42
(0.87%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.86 Billion CNY | -15.11% |
| 2022 | 2.19 Billion CNY | 213.25% |
| 2021 | 700.58 Million CNY | 72.47% |
| 2020 | 406.21 Million CNY | 102.62% |
| 2019 | 200.48 Million CNY | 75.0% |
| 2018 | 114.55 Million CNY | 24.2% |
| 2017 | 92.23 Million CNY | 43.28% |
| 2016 | 64.37 Million CNY | 24.3% |
| 2015 | 51.79 Million CNY | 39.82% |
| 2014 | 37.04 Million CNY | 352.38% |
| 2013 | 8.18 Million CNY | 248.27% |
| 2012 | 2.35 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.63 Billion CNY | -0.02% |
| 2024 Q1 | 1.69 Billion CNY | -9.04% |
| 2024 Q2 | 1.63 Billion CNY | -3.69% |
| 2023 Q4 | 1.86 Billion CNY | -12.25% |
| 2023 Q1 | 2.39 Billion CNY | 9.08% |
| 2023 FY | 1.86 Billion CNY | -15.11% |
| 2023 Q3 | 2.12 Billion CNY | -0.22% |
| 2023 Q2 | 2.12 Billion CNY | -11.12% |
| 2022 Q4 | 2.19 Billion CNY | -0.78% |
| 2022 FY | 2.19 Billion CNY | 213.25% |
| 2022 Q3 | 2.21 Billion CNY | 10.14% |
| 2022 Q2 | 2 Billion CNY | 131.79% |
| 2022 Q1 | 866.42 Million CNY | 23.67% |
| 2021 Q3 | 692.17 Million CNY | 20.78% |
| 2021 Q1 | 519.99 Million CNY | 28.01% |
| 2021 FY | 700.58 Million CNY | 72.47% |
| 2021 Q2 | 573.08 Million CNY | 10.21% |
| 2021 Q4 | 700.58 Million CNY | 1.22% |
| 2020 FY | 406.21 Million CNY | 102.62% |
| 2020 Q3 | 343.88 Million CNY | 26.01% |
| 2020 Q4 | 406.21 Million CNY | 18.13% |
| 2020 Q2 | 272.9 Million CNY | 17.28% |
| 2020 Q1 | 232.69 Million CNY | 16.07% |
| 2019 Q1 | 143.33 Million CNY | 25.12% |
| 2019 FY | 200.48 Million CNY | 75.0% |
| 2019 Q4 | 200.48 Million CNY | -8.26% |
| 2019 Q3 | 218.52 Million CNY | 24.28% |
| 2019 Q2 | 175.83 Million CNY | 22.68% |
| 2018 Q4 | 114.55 Million CNY | -11.79% |
| 2018 Q2 | 118.62 Million CNY | 5.62% |
| 2018 Q1 | 112.31 Million CNY | 21.77% |
| 2018 FY | 114.55 Million CNY | 24.2% |
| 2018 Q3 | 129.87 Million CNY | 9.48% |
| 2017 Q2 | 87.02 Million CNY | 0.0% |
| 2017 Q3 | 101.66 Million CNY | 16.82% |
| 2017 FY | 92.23 Million CNY | 43.28% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q4 | 92.23 Million CNY | -9.28% |
| 2016 FY | 64.37 Million CNY | 24.3% |
| 2016 Q4 | 64.37 Million CNY | 0.0% |
| 2015 FY | 51.79 Million CNY | 39.82% |
| 2014 FY | 37.04 Million CNY | 352.38% |
| 2013 FY | 8.18 Million CNY | 248.27% |
| 2012 FY | 2.35 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 1.37 Billion CNY | -35.305% |
| WuXi AppTec Co., Ltd. | 4.73 Billion CNY | 60.663% |
| Autobio Diagnostics Co., Ltd. | 778.28 Million CNY | -139.382% |
| Thalys Medical Technology Group Inc. | 341.6 Million CNY | -445.397% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 248.2 Million CNY | -650.615% |
| Chemclin Diagnostics Co., Ltd. | 110.6 Million CNY | -1584.443% |